MedPage Today coverage of the recent Genitourinary Cancers Symposium (GuCS) on February 13-15, 2025.
[u]Radiographic PFS in Metastatic CRPC More Than Doubles With Novel Combination — Improvement from 6.2 to 14.3 months with mevrometostat plus enzalutamide, but with more toxicity[/u], Meeting Coverage > GuCS, by Mike Bassett, Senior Editor, MedPage Today, February 13, 2025.
[u]Radiographic PFS in Metastatic CRPC More Than Doubles With Novel Combination — Improvement from 6.2 to 14.3 months with mevrometostat plus enzalutamide, but with more toxicity[/u], Meeting Coverage > GuCS, by Mike Bassett, Senior Editor, MedPage Today, February 13, 2025.